Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2025-12-24 @ 2:35 PM
NCT ID:
NCT00291759
Eligibility Criteria:
Inclusion Criteria:
* Invasive mammary carcinoma after radical treatment, without prior chemo/hormone/radiation therapy.
* At least 6 lymph nodes examined.
* Good or intermediate tumour differentiation.
* \<6 weeks before start of adjuvant therapy.
* Oestrogen or Progesterone positive
Exclusion Criteria:
* Premenopausal.
* Preoperative hormonal/antihormonal/radiation/cytoxic chemo. Second malignant tumour/status post second malignant tumour.
* In-situ/T4 carcinoma.
* Age \>80 years.
* World Health Organisation performance index \>3.
* Serious accompanying diseases
Healthy Volunteers:
False
Sex:
FEMALE
Maximum Age:
80 Years
Study:
NCT00291759
Study Brief:
Protocol Section:
NCT00291759